ONE RESEARCH WAY, PRINCETON, NJ
PMV Pharmaceuticals Elects Directors at 2026 Annual Meeting
Reports First Quarter 2026 Financial Results and Corporate Highlights
Annual Report to Security Holders
Financial Results, Press Release
Reports Third Quarter 2025 Financial Results and Corporate Highlights
Investor Presentation
Submission of Matters to a Vote of Security Holders
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
SC TO-I
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report